| Health / Medical Topics |
Varlitinib
An orally bioavailable inhibitor of the epidermal growth factor receptor family with potential antineoplastic activity. Varlitinib selectively and reversibly binds to both EGFR (ErbB-1) and Her-2/neu (ErbB-2) and prevents their phosphorylation and activation, which may result in inhibition of the associated signal transduction pathways, inhibition of cellular proliferation and cell death. EGFR and Her-2 play important roles in cell proliferation and differentiation and are upregulated in various human tumor cell types. Due to the dual inhibition of both EGFR and Her-2, this agent may be therapeutically more effective than agents that inhibit EGFR or Her-2 alone. (NCI Thesaurus)
YOU MAY ALSO LIKE
A semiconductor resistor device designed to have a voltage-dependent nonlinear resistance where resistance drops as the applied voltage increases.
An orthopoxvirus that is the causative agent of smallpox.
In botanical nomenclature, a rank below subspecies but above forma.
In pathology, a term that is used to describe a tissue specimen that exhibits different colors on its surfaces.
An autosomal dominant disorder of porphyria-heme metabolism. It is manifested with acute attacks including abdominal pain, vomiting, diarrhea, constipation, seizures, anxiety, and…
Varicose veins are swollen, twisted veins that you can see just under the skin. They usually occur in the legs, but also…
